Karin Olson

799 total citations
34 papers, 620 citations indexed

About

Karin Olson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Karin Olson has authored 34 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 9 papers in Radiation. Recurrent topics in Karin Olson's work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Advanced Radiotherapy Techniques (9 papers). Karin Olson is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Advanced Radiotherapy Techniques (9 papers). Karin Olson collaborates with scholars based in United States, Canada and India. Karin Olson's co-authors include Kenneth J. Pienta, Catherine Van Poznak, Daniel A. Hamstra, Howard M. Sandler, Kevin Blas, Felix Y. Feng, Schuyler Halverson, Laura E. Phelps, Robert D. Loberg and David C. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Karin Olson

33 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Olson United States	15	384	262	80	79	73	34	620
Sait Okkan Türkiye	15	173 0.5×	189 0.7×	130 1.6×	183 2.3×	96 1.3×	39	654
Jerzy Wydmański Poland	15	312 0.8×	247 0.9×	88 1.1×	196 2.5×	149 2.0×	76	721
Michael Farris United States	13	432 1.1×	303 1.2×	85 1.1×	96 1.2×	88 1.2×	70	678
Şefik İğdem Türkiye	16	148 0.4×	178 0.7×	92 1.1×	193 2.4×	88 1.2×	36	608
R. Jyothirmayi United Kingdom	13	142 0.4×	120 0.5×	20 0.3×	124 1.6×	38 0.5×	30	485
Gamze Uğurluer Türkiye	11	159 0.4×	89 0.3×	79 1.0×	84 1.1×	95 1.3×	50	373
Sughosh Dhakal United States	12	222 0.6×	198 0.8×	44 0.6×	83 1.1×	43 0.6×	29	488
Vassilios Vassiliou Cyprus	16	156 0.4×	350 1.3×	23 0.3×	396 5.0×	55 0.8×	41	679
P. Cellier France	10	176 0.5×	558 2.1×	49 0.6×	559 7.1×	72 1.0×	30	779
Nilendu Purandare India	13	315 0.8×	230 0.9×	18 0.2×	80 1.0×	102 1.4×	53	472

Countries citing papers authored by Karin Olson

Since Specialization

Citations

This map shows the geographic impact of Karin Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Olson more than expected).

Fields of papers citing papers by Karin Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Olson. The network helps show where Karin Olson may publish in the future.

Co-authorship network of co-authors of Karin Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Olson. A scholar is included among the top collaborators of Karin Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Olson. Karin Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jackson, Will, Felix Y. Feng, Stephanie Daignault, et al.. (2015). A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy. Advances in Radiation Oncology. 1(1). 59–66. 3 indexed citations

Vainshtein, Jeffrey M., Matthew J. Schipper, Sean Vance, et al.. (2014). Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy. American Journal of Clinical Oncology. 39(2). 173–180. 8 indexed citations

Feng, Felix Y., Kevin Blas, Karin Olson, et al.. (2013). Retrospective Evaluation Reveals That Long-term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 86(1). 64–71. 15 indexed citations

Hamstra, Daniel A., Dale W. Litzenberg, Will Jackson, et al.. (2012). Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1246–1253. 40 indexed citations

Bakker, Debra, Michael Conlon, Margaret I. Fitch, et al.. (2012). Canadian Oncology Nurse Work Environments: Part II. Nursing leadership. 25(1). 68–69. 9 indexed citations

Vainshtein, Jeffrey M., Eyad Abu‐Isa, Karin Olson, et al.. (2012). Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiation Oncology. 7(1). 82–82. 42 indexed citations

Moote, Marc, et al.. (2012). Physician assistant and nurse practitioner utilization in radiation oncology within an academic medical center. Practical Radiation Oncology. 2(4). e31–e37. 7 indexed citations

Halverson, Schuyler, Matthew J. Schipper, Kevin Blas, et al.. (2011). The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse. Radiotherapy and Oncology. 101(3). 513–520. 13 indexed citations

Sabolch, Aaron, Felix Y. Feng, Stephanie Daignault‐Newton, et al.. (2011). Gleason Pattern 5 Is the Greatest Risk Factor for Clinical Failure and Death From Prostate Cancer After Dose-Escalated Radiation Therapy and Hormonal Ablation. International Journal of Radiation Oncology*Biology*Physics. 81(4). e351–e360. 64 indexed citations

10.

Layman, Rachel M., Karin Olson, & Catherine Van Poznak. (2007). Bisphosphonates for Breast Cancer: Questions Answered, Questions Remaining. Hematology/Oncology Clinics of North America. 21(2). 341–367. 11 indexed citations

11.

Pienta, Kenneth J., Rodney L. Dunn, Kathleen A. Cooney, et al.. (2007). Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma. Clinical Genitourinary Cancer. 5(5). 318–322. 8 indexed citations

12.

Dunn, Rodney L., Beth A. Hellerstedt, Kathleen A. Cooney, et al.. (2006). Dose escalation of oral vinorelbine in combination with estramustine in hormone‐refractory adenocarcinoma of the prostate. Cancer. 106(12). 2617–2623. 2 indexed citations

13.

Bhandari, Manish, et al.. (2006). Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone‐refractory prostate carcinoma. Cancer. 106(8). 1715–1721. 6 indexed citations

14.

Ray, Michael E., Kirk J. Wojno, Neal S. Goldstein, et al.. (2006). Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate. Urology. 67(2). 423.e5–423.e8. 17 indexed citations

15.

Olson, Karin, John Hanson, Dawn Stacey, et al.. (2004). Évaluation de la fidélité et de la validité du système révisé de classification de la stomatite du WCCNR lorsqu’elle résulte d’un traitement anticancéreux. Canadian Oncology Nursing Journal. 14(3). 176–182. 1 indexed citations

16.

Olson, Karin, John Hanson, Dawn Stacey, et al.. (2004). Assessing the reliability and validity of the revised WCCNR Stomatitis Staging System for cancer therapy-induced stomatitis. Canadian Oncology Nursing Journal. 14(3). 168–174. 13 indexed citations

17.

Smith, David C., Christopher H. Chay, Rodney L. Dunn, et al.. (2003). Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone‐refractory prostate carcinoma. Cancer. 98(2). 269–276. 30 indexed citations

18.

Hellerstedt, Beth A., Kenneth J. Pienta, Bruce G. Redman, et al.. (2003). Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma. Cancer. 98(8). 1603–1610. 28 indexed citations

19.

Olson, Karin & Kenneth J. Pienta. (1999). Pain management in patients with advanced prostate cancer.. PubMed. 13(11). 1537–49; discussion 1549. 20 indexed citations

20.

Olson, Karin, et al.. (1998). Assessing stomatitis: Refinement of the Western Consortium for Cancer Nursing Research (WCCNR) stomatitis staging system. Canadian Oncology Nursing Journal. 8(3). 160–162. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact